List of Contributors |
|
xvii | |
Preface |
|
xix | |
Glossary of Terms |
|
xxvii | |
Acknowledgments |
|
xxxv | |
Part I Thrusts |
|
|
Macro-level Thrusts (MaTs) |
|
|
|
1 Organizational Structure |
|
|
1 | (20) |
|
|
1.1 Introduction to the Healthcare Industry |
|
|
2 | (4) |
|
1.2 Academic Medical Centers |
|
|
6 | (10) |
|
1.3 Community Hospitals and Physicians |
|
|
16 | (3) |
|
|
19 | (2) |
|
|
21 | (10) |
|
|
|
21 | (6) |
|
|
27 | (2) |
|
2.3 Opportunity for Action |
|
|
29 | (2) |
|
|
31 | (20) |
|
|
|
31 | (1) |
|
3.2 Matching Doctors to Residency Programs |
|
|
31 | (1) |
|
|
31 | (1) |
|
3.2.2 A Centralized Market and New Challenges |
|
|
32 | (1) |
|
|
33 | (2) |
|
|
35 | (1) |
|
|
35 | (1) |
|
3.3.2 Creating a Thick Marketplace for Kidney Exchange |
|
|
36 | (1) |
|
|
38 | (1) |
|
3.3.4 The Marketplace for Kidney Exchange in the United States |
|
|
41 | (1) |
|
3.3.5 Final Comments on Kidney Exchange |
|
|
43 | (1) |
|
|
44 | (7) |
|
Meso-level Thrusts (MeTs) |
|
|
|
|
51 | (28) |
|
|
|
51 | (2) |
|
4.2 The Literature on Competing Interests |
|
|
53 | (1) |
|
4.2.1 Evaluation of Pharmaceutical Products |
|
|
53 | (1) |
|
4.2.1.1 Individual Drug Classes |
|
|
54 | (1) |
|
4.2.1.2 Multiple Interventions |
|
|
55 | (1) |
|
|
56 | (1) |
|
4.2.2 Physician Ownership |
|
|
56 | (1) |
|
4.2.2.1 Physician Ownership of Ancillary Services |
|
|
57 | (1) |
|
4.2.2.2 Physician Ownership of Ambulatory Surgery Centers |
|
|
59 | (1) |
|
4.2.2.3 Physician Ownership of Speciality Hospitals |
|
|
60 | (1) |
|
4.2.2.4 Physician-Owned Distributors |
|
|
61 | (1) |
|
|
62 | (1) |
|
|
63 | (1) |
|
|
64 | (1) |
|
|
65 | (1) |
|
4.3.1 Example 1: Physician Decisions with Competing Interests |
|
|
66 | (1) |
|
4.3.2 Example 2: Evidence of HAI Upcoding |
|
|
70 | (2) |
|
4.4 Summary and Future Work |
|
|
72 | (1) |
|
|
73 | (6) |
|
|
79 | (30) |
|
|
|
5.1 Frameworks for Measuring Healthcare Quality |
|
|
79 | (1) |
|
5.1.1 The Donabedian Model |
|
|
79 | (1) |
|
|
81 | (1) |
|
5.2 Understanding Healthcare Quality: Classification of the Existing OR/MS Literature |
|
|
82 | (1) |
|
|
82 | (1) |
|
|
85 | (1) |
|
|
91 | (1) |
|
|
92 | (1) |
|
|
94 | (1) |
|
5.3 Open Areas for Future Research |
|
|
95 | (1) |
|
5.3.1 Understanding Structures and Their Interactions with Processes and Outcomes |
|
|
95 | (1) |
|
5.3.2 Understanding Patient Experiences and Their Interactions with Structure |
|
|
96 | (1) |
|
5.3.3 Understanding Processes and Their Interactions with Outcomes |
|
|
97 | (1) |
|
5.3.4 Understanding Access to Care |
|
|
98 | (1) |
|
|
98 | (1) |
|
|
99 | (1) |
|
|
99 | (10) |
|
|
109 | (28) |
|
|
|
|
109 | (2) |
|
6.2 Sequential Decision Disease Models with Health Information Updates |
|
|
111 | (1) |
|
6.2.1 Case Study: POMDP Model for Personalized Breast Cancer Screening |
|
|
113 | (1) |
|
6.2.2 Case Study: Kalman Filter for Glaucoma Monitoring |
|
|
116 | (1) |
|
6.2.3 Other Relevant Studies |
|
|
118 | (2) |
|
6.3 One-Time Decision Disease Models with Risk Stratification |
|
|
120 | (1) |
|
6.3.1 Case Study: Subtype-Based Treatment for DLBCL |
|
|
121 | (1) |
|
|
124 | (1) |
|
6.4 Artificial Intelligence-Based Approaches |
|
|
125 | (1) |
|
6.4.1 Learning from Existing Health Data |
|
|
126 | (1) |
|
6.4.2 Learning from Trial and Error |
|
|
127 | (1) |
|
6.5 Conclusions and Emerging Future Research Directions |
|
|
128 | (2) |
|
|
130 | (7) |
|
|
137 | (22) |
|
|
Jayashankar M. Swaminathan |
|
|
|
137 | (2) |
|
7.2 Funding Allocation in Global Health Settings |
|
|
139 | (1) |
|
7.2.1 Funding Allocation for Disease Prevention |
|
|
139 | (1) |
|
7.2.2 Funding Allocation for Treatment of Disease Conditions |
|
|
143 | (1) |
|
|
143 | (1) |
|
|
146 | (1) |
|
7.3 Inventory Allocation in Global Health Settings |
|
|
147 | (1) |
|
7.3.1 Inventory Allocation for Disease Prevention |
|
|
147 | (1) |
|
7.3.2 Inventory Allocation for Treatment of Disease Conditions |
|
|
149 | (4) |
|
7.4 Capacity Allocation in Global Health Settings |
|
|
153 | (2) |
|
7.5 Conclusions and Future Directions |
|
|
155 | (1) |
|
|
156 | (3) |
|
8 Healthcare Supply Chain |
|
|
159 | (28) |
|
|
|
|
159 | (3) |
|
|
162 | (2) |
|
|
164 | (1) |
|
8.3.1 Generic Injectable Drug Supply Chain |
|
|
164 | (1) |
|
|
166 | (1) |
|
|
168 | (3) |
|
8.3.2 Influenza Vaccine Supply Chain |
|
|
171 | (1) |
|
|
172 | (1) |
|
|
173 | (4) |
|
8.4 Discussion and Future Research |
|
|
177 | (3) |
|
|
180 | (2) |
|
|
182 | (1) |
|
|
182 | (5) |
|
|
187 | (30) |
|
|
|
|
|
187 | (2) |
|
9.2 The Deceased-Donor Organ Allocation system: Stakeholders and Their Objectives |
|
|
189 | (10) |
|
9.3 Research Opportunities in the Area |
|
|
199 | (1) |
|
9.3.1 Past Research on the Transplant Candidate's Problem |
|
|
199 | (1) |
|
9.3.2 Challenges in Modeling Patient Choice |
|
|
201 | (1) |
|
9.3.3 Past Research on the Deceased-donor Organ Allocation Policy |
|
|
202 | (1) |
|
9.3.4 Challenges in Modeling the Deceased-donor Organ Allocation Policy |
|
|
206 | (1) |
|
9.3.5 Research Problems from the Perspective of Other Stakeholders |
|
|
206 | (2) |
|
|
208 | (1) |
|
|
209 | (8) |
|
Micro-level Thrusts (MiTs) |
|
|
|
|
217 | (26) |
|
|
|
217 | (1) |
|
10.2 How Operations are Managed in Primary Care Practice |
|
|
218 | (1) |
|
10.3 What Makes Operations Management Difficult in Ambulatory Care |
|
|
220 | (1) |
|
10.3.1 Competing Objectives |
|
|
220 | (1) |
|
10.3.2 Environmental Factors |
|
|
221 | (1) |
|
10.4 Operations Management Models |
|
|
222 | (1) |
|
10.4.1 System-Wide Planning |
|
|
222 | (1) |
|
10.4.2 Appointment Template Design |
|
|
226 | (1) |
|
10.4.3 Managing Patient Flow |
|
|
231 | (3) |
|
10.5 New Trends in Ambulatory Care |
|
|
234 | (1) |
|
|
234 | (1) |
|
|
235 | (1) |
|
10.5.3 Retail Approach of Outpatient Care |
|
|
236 | (1) |
|
|
237 | (1) |
|
|
237 | (6) |
|
|
243 | (14) |
|
|
11.1 Modeling the Inpatient Ward |
|
|
244 | (1) |
|
11.2 Inpatient Ward Policies |
|
|
246 | (1) |
|
|
247 | (1) |
|
11.4 Interface with Elective Surgeries |
|
|
248 | (1) |
|
|
250 | (1) |
|
11.6 Incentive, Behavioral, and Organizational Issues |
|
|
251 | (1) |
|
|
252 | (1) |
|
11.7.1 Essential Quantitative Tools |
|
|
253 | (1) |
|
11.7.2 Resources for Learners |
|
|
253 | (1) |
|
|
253 | (4) |
|
|
257 | (30) |
|
|
|
|
12.1 Overview of Home Care Delivery |
|
|
257 | (1) |
|
|
258 | (1) |
|
|
258 | (1) |
|
|
259 | (1) |
|
12.1.2.2 Specialized Programs |
|
|
259 | (1) |
|
12.1.3 Operational Challenges |
|
|
260 | (1) |
|
12.1.3.1 Discussion of the Planning Horizon |
|
|
262 | (1) |
|
12.1.3.2 Home Care Planning Problem |
|
|
263 | (1) |
|
12.2 An Overview of Optimization Technology |
|
|
263 | (1) |
|
12.2.1 Linear Programming |
|
|
263 | (1) |
|
12.2.2 Mixed Integer Programming |
|
|
264 | (1) |
|
12.2.3 Constraint Programming |
|
|
265 | (1) |
|
12.2.4 Heuristics and Dedicated Methods |
|
|
265 | (1) |
|
12.2.5 Technology Comparison |
|
|
266 | (1) |
|
12.2.5.1 Solution Expectations and Solver Capabilities |
|
|
266 | (1) |
|
12.2.5.2 Development Time and Maintenance |
|
|
267 | (1) |
|
12.3 Territory Districting |
|
|
267 | (1) |
|
12.4 Provider-to-Patient Assignment |
|
|
270 | (1) |
|
|
270 | (1) |
|
|
271 | (1) |
|
|
272 | (1) |
|
12.4.4 Assignment of New Patients |
|
|
273 | (1) |
|
12.5 Task Scheduling and Routing |
|
|
273 | (1) |
|
|
276 | (1) |
|
12.6.1 Integrated Decision-Making Under a New Business Model |
|
|
277 | (1) |
|
12.6.2 Home Telemetering Forecasting Adverse Events |
|
|
277 | (1) |
|
12.6.3 Forecasting the Wound Healing Process |
|
|
278 | (1) |
|
12.6.4 Adjustment of Capacity and Demand |
|
|
279 | (1) |
|
|
280 | (7) |
|
|
287 | (32) |
|
|
|
|
287 | (1) |
|
|
291 | (1) |
|
13.3 Concierge Option-No Abandonment |
|
|
293 | (1) |
|
13.3.1 A Given Participation Level α |
|
|
294 | (1) |
|
|
295 | (1) |
|
13.3.2.1 All Customers Are Better Off |
|
|
295 | (1) |
|
13.3.2.2 Customers Are Better Off on Average |
|
|
297 | (2) |
|
13.3.3 Optimal Participation Level |
|
|
299 | (2) |
|
13.4 Concierge Option-Abandonment |
|
|
301 | (1) |
|
13.4.1 Choosing the Optimal α and β |
|
|
;303 | |
|
13.5 Correlated Service Times and Waiting Costs |
|
|
304 | (1) |
|
|
306 | (1) |
|
|
307 | (1) |
|
13.6.2 Abandonment Model Applied to MDVIP Data |
|
|
308 | (1) |
|
13.6.2.1 Modeling Heterogeneous Waiting Costs |
|
|
309 | (1) |
|
13.6.2.2 Participation in Concierge Medicine |
|
|
310 | (1) |
|
13.6.2.3 Impact of Concierge Medicine |
|
|
310 | (1) |
|
13.6.2.4 Choosing the Concierge Participation Level |
|
|
312 | (1) |
|
13.7 Research Opportunities |
|
|
313 | (1) |
|
|
316 | (3) |
Part II Tools |
|
|
14 Markov Decision Processes |
|
|
319 | (18) |
|
|
|
319 | (2) |
|
|
321 | (4) |
|
|
325 | (3) |
|
|
325 | (2) |
|
14.3.2 Analytical Results |
|
|
327 | (1) |
|
|
328 | (1) |
|
14.4 Modifications and Extensions of MDPs |
|
|
328 | (4) |
|
14.4.1 Imperfect State Information |
|
|
328 | (1) |
|
14.4.2 Extremely Large or Continuous State Spaces |
|
|
329 | (1) |
|
14.4.3 Uncertainty about Transition Probabilities |
|
|
330 | (1) |
|
14.4.4 Constrained Optimization |
|
|
331 | (1) |
|
|
332 | (1) |
|
14.6 Recommendations for Additional Reading |
|
|
333 | (1) |
|
|
334 | (3) |
|
15 Game Theory and Information Economics |
|
|
337 | (18) |
|
|
|
337 | (2) |
|
|
339 | (4) |
|
15.2.1 Game Theory: Key Concepts |
|
|
339 | (1) |
|
15.2.2 Information Economics: Key Concepts |
|
|
340 | (1) |
|
15.2.2.1 Nonobservability of Information |
|
|
341 | (1) |
|
15.2.2.2 Asymmetric Information |
|
|
341 | (2) |
|
15.3 Summary of Healthcare Applications |
|
|
343 | (5) |
|
15.3.1 Incentive Design for Healthcare Providers |
|
|
344 | (1) |
|
15.3.2 Quality-Speed Tradeoff |
|
|
345 | (1) |
|
|
346 | (1) |
|
15.3.4 Healthcare Supply Chain |
|
|
346 | (1) |
|
|
346 | (1) |
|
15.3.6 Organ Transplantation |
|
|
347 | (1) |
|
15.3.7 Healthcare Network |
|
|
347 | (1) |
|
15.3.8 Mixed Motives of Healthcare Providers |
|
|
347 | (1) |
|
15.4 Potential Applications |
|
|
348 | (3) |
|
15.4.1 Micro-Level applications |
|
|
348 | (1) |
|
15.4.2 Macro-Level Applications |
|
|
349 | (1) |
|
15.4.3 Meso-Level Applications |
|
|
349 | (2) |
|
15.5 Resources for Learners |
|
|
351 | (1) |
|
|
351 | (4) |
|
|
355 | (26) |
|
|
|
355 | (1) |
|
16.1.1 Scope of the Review |
|
|
356 | (1) |
|
16.2 Basic Queueing Models |
|
|
356 | (9) |
|
16.2.1 Components of a Queueing System |
|
|
356 | (1) |
|
16.2.2 Performance Measures |
|
|
357 | (1) |
|
|
358 | (1) |
|
|
359 | (1) |
|
|
360 | (1) |
|
|
361 | (1) |
|
16.2.6.1 Achievable Region Approach |
|
|
363 | (1) |
|
16.2.7 Networks of Queues |
|
|
364 | (1) |
|
|
364 | (1) |
|
|
365 | (11) |
|
16.3.1 Waiting as an Equilibrium Device |
|
|
366 | (1) |
|
16.3.2 Demand Dependent on Service Time |
|
|
367 | (2) |
|
16.3.3 Physician-Induced Demand |
|
|
369 | (1) |
|
|
370 | (1) |
|
16.3.4.1 Observable Queue |
|
|
370 | (1) |
|
16.3.4.2 Unobservable Queue |
|
|
371 | (2) |
|
16.3.5 Waiting for a Better Match |
|
|
373 | (3) |
|
16.4 Discussion and Future Research Directions |
|
|
376 | (1) |
|
|
376 | (5) |
|
|
381 | (22) |
|
|
|
381 | (1) |
|
17.2 Statistical Modeling |
|
|
382 | (4) |
|
17.2.1 Statistical Inference |
|
|
383 | (1) |
|
|
384 | (2) |
|
17.3 The Experimental Ideal and the Search for Exogenous Variation |
|
|
386 | (9) |
|
17.3.1 Instrumental Variables |
|
|
386 | (1) |
|
17.3.1.1 Example 1 (IV): Patient Flow through an Intensive Care Unit |
|
|
388 | (1) |
|
17.3.1.2 Example 2 (IV): Focused Factories |
|
|
391 | (1) |
|
17.3.2 Difference Estimators |
|
|
392 | (2) |
|
17.3.3 Fixed Effects Estimators |
|
|
394 | (1) |
|
17.3.3.1 Examples 3-4 (D-in-D): Process Compliance and Peer Effects of Productivity |
|
|
395 | (1) |
|
17.4 Structural Estimation |
|
|
395 | (4) |
|
17.4.1 Example 5: Managing Operating Room Capacity |
|
|
396 | (1) |
|
17.4.2 Example 6: Patient Choice Modeling |
|
|
397 | (2) |
|
|
399 | (1) |
|
|
400 | (3) |
|
|
403 | (26) |
|
|
|
403 | (7) |
|
|
404 | (3) |
|
|
407 | (1) |
|
18.1.3 Attribute Selection and Ranking |
|
|
408 | (1) |
|
18.1.4 Information Gain (IG) Attribute Ranking |
|
|
408 | (1) |
|
18.1.5 Relief-F Attribute Ranking |
|
|
408 | (1) |
|
18.1.6 Markov Blanket Feature Selection |
|
|
408 | (1) |
|
18.1.7 Correlation-Based Feature Selection |
|
|
409 | (1) |
|
|
409 | (1) |
|
18.2 Three Illustrative Examples of Data Science in Healthcare |
|
|
410 | (9) |
|
18.2.1 Medication Reconciliation |
|
|
410 | (3) |
|
18.2.2 Dynamic Prediction of Medical Risks |
|
|
413 | (3) |
|
18.2.3 Practice-Based Clinical Pathway Learning |
|
|
416 | (3) |
|
|
419 | (3) |
|
18.3.1 Challenges and Opportunities |
|
|
419 | (1) |
|
18.3.2 Data Science in Action |
|
|
420 | (1) |
|
18.3.3 Health Data Science Worldwide |
|
|
421 | (1) |
|
|
421 | (1) |
|
|
422 | (7) |
Index |
|
429 | |